These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38834158)
1. Cannabis use in Parkinson's disease: Patient access to medical cannabis and physician perspective on product safety. Griffith ST; Conrow KD; Go M; McEntee ML; Daniulaityte R; Nadesan MH; Swinburne MR; Shill HA; Leung MCK Neurotoxicology; 2024 Jul; 103():198-205. PubMed ID: 38834158 [TBL] [Abstract][Full Text] [Related]
2. Comparison of State-Level Regulations for Cannabis Contaminants and Implications for Public Health. Jameson LE; Conrow KD; Pinkhasova DV; Boulanger HL; Ha H; Jourabchian N; Johnson SA; Simeone MP; Afia IA; Cahill TM; Orser CS; Leung MCK Environ Health Perspect; 2022 Sep; 130(9):97001. PubMed ID: 36102653 [TBL] [Abstract][Full Text] [Related]
3. Advice to People with Parkinson's in My Clinic: Cannabis. de Freitas MET; Fox SH J Parkinsons Dis; 2024; 14(4):873-881. PubMed ID: 38759024 [TBL] [Abstract][Full Text] [Related]
4. Natural Health Products for Symptomatic Relief of Parkinson's Disease: Prevalence, Interest, and Awareness. Diadhiou S; Maas BR; Schootemeijer S; Bloem BR; de Vries NM; Calon F; Darweesh SKL; de Rus Jacquet A J Parkinsons Dis; 2024; 14(6):1257-1264. PubMed ID: 38943398 [TBL] [Abstract][Full Text] [Related]
5. U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020 : An Observational Study. Boehnke KF; Dean O; Haffajee RL; Hosanagar A Ann Intern Med; 2022 Jul; 175(7):945-951. PubMed ID: 35696691 [TBL] [Abstract][Full Text] [Related]
6. Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022. Boehnke KF; Sinclair R; Gordon F; Hosanagar A; Roehler DR; Smith T; Hoots B Ann Intern Med; 2024 Apr; 177(4):458-466. PubMed ID: 38588545 [TBL] [Abstract][Full Text] [Related]
7. Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review. Figura M; Koziorowski D; Sławek J Neurol Neurochir Pol; 2022; 56(1):21-27. PubMed ID: 34985112 [TBL] [Abstract][Full Text] [Related]
8. Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease. Shih LC; Tarsy D Neuromodulation; 2011; 14(3):208-13; discussion 213. PubMed ID: 21992241 [TBL] [Abstract][Full Text] [Related]
9. An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania. Kimless D; Caloura M; Markos V; Ryan J; Abbonizio S; Janicki S J Prim Care Community Health; 2022; 13():21501319221129734. PubMed ID: 36226444 [TBL] [Abstract][Full Text] [Related]
10. Education, Knowledge, and Practice Characteristics of Cannabis Physicians: A Survey of the Society of Cannabis Clinicians. Takakuwa KM; Mistretta A; Pazdernik VK; Sulak D Cannabis Cannabinoid Res; 2021; 6(1):58-65. PubMed ID: 33614953 [No Abstract] [Full Text] [Related]
11. Cannabis in Parkinson's Disease: The Patients' View. Yenilmez F; Fründt O; Hidding U; Buhmann C J Parkinsons Dis; 2021; 11(1):309-321. PubMed ID: 33216043 [TBL] [Abstract][Full Text] [Related]
12. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. Philpot LM; Ebbert JO; Hurt RT BMC Fam Pract; 2019 Jan; 20(1):17. PubMed ID: 30669979 [TBL] [Abstract][Full Text] [Related]
13. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation. Kindred JH; Li K; Ketelhut NB; Proessl F; Fling BW; Honce JM; Shaffer WR; Rudroff T Complement Ther Med; 2017 Aug; 33():99-104. PubMed ID: 28735833 [TBL] [Abstract][Full Text] [Related]
14. [Cannabis in Parkinson's Disease: Hype or help?]. Mainka T; Stork J; Hidding U; Buhmann C Fortschr Neurol Psychiatr; 2018 Feb; 86(2):106-116. PubMed ID: 29325182 [TBL] [Abstract][Full Text] [Related]
15. Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease. Shohet A; Khlebtovsky A; Roizen N; Roditi Y; Djaldetti R Eur J Pain; 2017 Mar; 21(3):486-493. PubMed ID: 27723182 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Parkinson's disease: a survey of patients and neurologists. Fargel M; Grobe B; Oesterle E; Hastedt C; Rupp M Clin Drug Investig; 2007; 27(3):207-18. PubMed ID: 17305415 [TBL] [Abstract][Full Text] [Related]
17. Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists. Szaflarski M; McGoldrick P; Currens L; Blodgett D; Land H; Szaflarski JP; Segal E Epilepsy Behav; 2020 Aug; 109():107102. PubMed ID: 32442891 [TBL] [Abstract][Full Text] [Related]
18. A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment. Weiss MC; Hibbs JE; Buckley ME; Danese SR; Leitenberger A; Bollmann-Jenkins M; Meske SW; Aliano-Ruiz KE; McHugh TW; Larson SL; Le EH; Green NL; Gilman PB; Kaklamani VG; Chlebowski RT; Martinez DM Cancer; 2022 Jan; 128(1):160-168. PubMed ID: 34636036 [TBL] [Abstract][Full Text] [Related]